Skip to main content
    V

    Valneva SE ADR (VALN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.65
    -0.01 (-0.18%)

    Market Cap: $538.42M

    Last updated: Nov 17, 2026 at 10:33 AM ET

    Valneva SE ADR (VALN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Valneva SE ADR are DBV Technologies (DBVT), Nuvectis Pharma (NVCT) and Pharming Group NV (PHAR). By market cap, Valneva SE ADR ranks 8th of the 13 companies on this page; Novavax (NVAX) is the largest at $1.41B.

    Peer Comparison

    VALN's ROIC of -44.2% is above the peer median of -74.1%, and its revenue growth of -27.7% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Valneva SE ADR (VALN)$538.42MN/A3.2x-110.3%-44.2%-27.7%0.00%
    DBV Technologies (DBVT)$692.19MN/AN/A0.0%-130.3%-42.9%0.00%
    Nuvectis Pharma Inc (NVCT)$696.03MN/AN/A0.0%N/A0.0%0.00%
    Pharming Group NV (PHAR)$891.80M39.3x2.4x6.3%7.9%20.8%0.00%
    Zevra Therapeutics Inc. (ZVRA)$540.30M11.6x3.7x52.8%N/A44.9%0.00%
    Novavax Inc (NVAX)$1.41BN/A3.2x-18.6%-66.6%-3.0%0.00%
    Neurogene Inc (NGNE)$495.37MN/AN/A0.0%-28.5%0.0%0.00%
    CureVac NV (CVAC)$1.05BN/A1.8x182.1%N/A-89.0%0.00%
    Tevogen Bio Holdings Inc. (TVGN)$406.59MN/AN/A0.0%2022.8%0.0%0.00%
    Vanda Pharmaceuticals Inc (VNDA)$241.27MN/A1.0x-119.9%-84.7%24.1%0.00%
    Prothena Corporation plc (PRTA)$419.01MN/A7.8x-45.4%N/A-74.3%0.00%
    Inventiva Sa (IVA)$879.90MN/A133.4x0.0%-327.7%-76.7%0.00%
    Kyverna Therapeutics, Inc. Common Stock (KYTX)$319.27MN/AN/A0.0%-81.5%0.0%0.00%
    Peer median$616.25M25.5x3.2x0.0%-74.1%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Valneva SE ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    DBV Technologies (DBVT)
    DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products.
    DBVT competitors
    Nuvectis Pharma Inc (NVCT)
    Nuvectis Pharma, Inc., a biopharmaceutical company, is focused on the development of targeted small molecule therapies for the treatment of cancer.
    NVCT competitors
    Pharming Group NV (PHAR)
    Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States...
    PHAR competitors
    Zevra Therapeutics Inc. (ZVRA)
    Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions...
    ZVRA competitors
    Novavax Inc (NVAX)
    Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases...
    NVAX competitors
    Neurogene Inc (NGNE)
    Neurogene Inc. is an innovative biotechnology company at the forefront of developing advanced gene therapies for rare neurological disorders...
    NGNE competitors
    CureVac NV (CVAC)
    CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA).
    Tevogen Bio Holdings Inc. (TVGN)
    Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology...
    TVGN competitors
    Vanda Pharmaceuticals Inc (VNDA)
    Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs.
    VNDA competitors
    Prothena Corporation plc (PRTA)
    Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases...
    PRTA competitors
    Inventiva Sa (IVA)
    Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic...
    Kyverna Therapeutics, Inc. Common Stock (KYTX)
    Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health...
    KYTX competitors

    Frequently Asked Questions About VALN

    Who are Valneva SE ADR's main competitors?

    The companies most similar to Valneva SE ADR include DBV Technologies (DBVT), Nuvectis Pharma (NVCT), Pharming Group NV (PHAR), Zevra Therapeutics (ZVRA) and Novavax (NVAX), listed from the closest match.

    Who is Valneva SE ADR's biggest competitor?

    Novavax (NVAX) is the largest of the similar companies at $1.41B; DBV Technologies (DBVT) is the closest match by business profile, size, sector and industry.

    How does VALN stock compare with its competitors?

    VALN's P/S is 3.2x against a peer median of 3.2x; its net margin is -110.3% against a peer median of 0.0%.

    Which of Valneva SE ADR's competitors pays a higher dividend?

    Valneva SE ADR pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Valneva SE ADR bigger than its competitors?

    No. Valneva SE ADR is 8th by market cap among the 13 companies on this page; the largest is Novavax (NVAX) at $1.41B.